Difference between revisions of "Al Shahrani M"
From Bioblast
m (moved Al-Sharani Mesfer to Al-Sharani M) |
|||
| Line 7: | Line 7: | ||
|address=Queen Square | |address=Queen Square | ||
|city=London | |city=London | ||
|country= | |country=United Kingdom | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
Revision as of 17:07, 21 January 2015
| Name | Al-Sharani Mesfer, |
|---|---|
| Institution | The National Hospital for Neurology & Neurosurgery
Neurometabolic Unit |
| Address | Queen Square, |
| City | London |
| State/Province | |
| Country | United Kingdom |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | UK London Land JM |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hargreaves 2016 Drug Saf | 2016 | Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJR (2016) Drug-induced mitochondrial toxicity. Drug Saf 39:661–74. https://doi.org/10.1007/s40264-016-0417-x. |
